ESG Report 2023

7 3.2 Entering The United Laboratories The Group is a comprehensive and modernized pharmaceutical enterprise engaged in the research and development, production and operation, and the products covering pharmaceutical intermediate products, bulk medicines, finished products, veterinary drugs, empty capsules and medical devices. The Group currently has seven major production sites including The United Laboratories Co., Ltd. (“Hong Kong Company”), Zhuhai United Laboratories Co., Ltd. (“Zhuhai Company”), Zhuhai United Laboratories Co. Ltd. Zhongshan Branch (“Zhongshan Company”), Guangdong Kaiping Kingly Capsule Co., Ltd., United Laboratories (Inner Mongolia Company) Co., Ltd. (“Inner Mongolia Company”), The United Animal Healthcare (Inner Mongolia) Co., Ltd. (“The United Animal Healthcare”), and Kendor Technology (Zhejiang) Co., Ltd. (“Kendor Company”) with a total of approximately 15,000 employees. 3.2.1 Introduction of the Group Since its establishment, the Group has been dedicating to the production of high-quality pharmaceuticals. All our factories have attained the certification of Chinese Good Manufacturing Practice (“cGMP”), and multiple products have obtained official certifications such as the Certification of Suitability to the Monographs of the European Pharmacopoeia Organisation and the US Food and Drug Administration (“FDA”). We adhere to self-innovations and possess strong research and development capabilities. Our products cover multiple fields including antibiotics, diabetes drugs, nervous system drugs, ophthalmology drugs, topical dermatology drugs and others. Many scientific and technological achievements of the Group have obtained national patents. Talents are the primary productive force of an enterprise. The Group emphasizes high-quality work force construction, continuously improves human resource management, establishes and improves our talent training, selection and education mechanism, and has gradually formed a “Friendly, Responsible, Hardworking and Efficient” workforce. We always adhere to the philosophy of “To Make Life More Valuable” to promote the development of environmental protection and the charity sector with a high sense of social responsibility. As for environmental protection, we have made huge investment in creating a green enterprise. We actively support charities in multiple fields such as education, poverty alleviation and social welfare. Our efforts have been recognised by social community, which reflected our responsibilities and missions as a modern enterprise. In the future, the Group will continue to dedicate its efforts to the creation of an outstanding Chinese pharmaceutical brand, promote the development of the national medical and healthcare industry, and create more high-quality and highly effective pharmaceuticals. 3.2.2 Concept and Vision Love China, For China Corporate Mission To Make Life More Valuable Corporate Tenet To Manufacture First-class Products, Provide First-class Service, Cultivate First-class Professionals, be a Model in the Pharmaceutical Industry Corporate Objective (Vision) Pragmatic and Rigorous, Scientific Truth-seeking, Future-oriented, and Innovative R&D Philosophy Friendship, Equality, and Joint Development Business Principle We Cherish not only Economic Benefits, but also Green Mountains and Lucid Water, Blue Sky and White Clouds Devoted to Producing Safe and Effective Medicines for the Chinese People Environmental Protection Concept Core Value Kind, Conscientious, Diligent and Highly-efficient Core Culture Environmental, Social and Governance Report 2023 The United Laboratories International Holdings Limited